Ectopic Expression of the CRF‐binding Protein: Minor Impact on HPA Axis Regulation but Induction of Sexually Dimorphic Weight Gain
- 1 July 1998
- journal article
- research article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 10 (7) , 483-491
- https://doi.org/10.1046/j.1365-2826.1998.00206.x
Abstract
Corticotrophin-releasing factor (CRF) and urocortin possess a high-affinity binding protein. Although the CRF binding protein (BP) can sequester these ligands and inhibit their activity, the endogenous activity of this protein is not understood. Therefore, transgenic mouse lines that over-express the CRF-BP were created. The transgene was constructed by ligating rat CRF-BP cDNA (1.1 kb) between a mouse metallothionein-I promoter (1.8 kb) and a nonfunctional human growth hormone gene sequence (2.1 kb) in a modified pBR322 plasmid and microinjecting the transgene into C57BL/6×SJL hybrid ova. The transgene was expressed in 50% in both male and female progeny. All transgenic lines were maintained by crossing transgenic animals with wild-type C57BL/6 mates. Reverse-transcriptase (RT) PCR of the CRF-BP transgene showed that it is widely expressed not only in the brain and pituitary, but also peripheral tissues including the liver, kidney and spleen. Transgenic animals of both sexes showed significant increases in weight gain as established by analysis of variance; however, the weight gain profiles for each sex were distinct. High levels of circulating CRF-BP were detected in the transgenic animals, but the basal ACTH and corticosterone levels were not significantly decreased compared to wild-type littermates. The hypothalamo–pituitary–adrenal (HPA) axis was stimulated by systemic inflammation induced with lipopolysaccharide (LPS). An expected increase in transgene expression was observed and was accompanied by a significant attenuation of ACTH secretion at 3 h after LPS injection in the transgenic males but not the females. These data suggest that HPA axis regulation is significantly affected only with very high circulating levels of CRF-BP. Moreover, this work supports previous studies that implicate CRF and urocortin in the regulation of appetite and the binding protein expression may play a sexually dimorphic role in regulating this and other responses.Keywords
This publication has 60 references indexed in Scilit:
- Comparison of Osborne‐Mendel and S5B/PL Strains of Rat: Central Effects of Galanin, NPY, β‐Casomorphin and CRH on Intake of High‐Fat and Low‐Fat DietsObesity Research, 1996
- Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding proteinMolecular and Cellular Endocrinology, 1995
- Growth hormone secretion: The role of glucocorticoidsLife Sciences, 1994
- Hypothalamic Neuropeptide Y Messenger Ribonucleic Acid Levels in Pre‐Obese and Genetically Obese (fa/fa) Rats; Potential Regulation Thereof by Corticotropin‐Releasing FactorJournal of Neuroendocrinology, 1993
- Neuroanatomical connections between corticotropin-releasing factor (CRF) and somatostatin (SRIF) nerve endings and thyrotropin-releasing hormone (TRH) neurons in the paraventricular nucleus of rat hypothalamusPeptides, 1992
- Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteinsNature, 1991
- Central effects of CRF on metabolism and energy balanceNeuroscience & Biobehavioral Reviews, 1990
- Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesisBrain Research, 1988
- Differential expression of four linked sheep metallothionein genesEuropean Journal of Biochemistry, 1988
- Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasmaBiochemical and Biophysical Research Communications, 1987